(Q46526072)

22 December 2017

title

HIV protease and the pathogenesis of AIDS. (English)

1 reference

22 December 2017

author name string

Goldberg B

series ordinal

1

1 reference

22 December 2017

Stricker RB

series ordinal

2

1 reference

22 December 2017

publication date

1 November 1996

1 reference

22 December 2017

published in

Research in Virology

1 reference

22 December 2017

volume

147

1 reference

22 December 2017

page(s)

375-379

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

HIV-1 protease cleaves actin during acute infection of human T-lymphocytes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

HIV protease inhibitors: effects on viral maturation and physiologic function in macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

Enhancement of HIV-specific cytotoxic T lymphocyte responses by zidovudine (AZT) treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

Activated T lymphocytes and macrophages secrete fibronectin which strongly supports cell adhesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

Plasma viral load, CD4+ cell counts, and HIV-1 production by cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

Substrates of human hepatic cytochrome P450 3A4.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

Relationships of human immunodeficiency virus protease with eukaryotic aspartic proteases

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

Mononuclear phagocytes as targets, tissue reservoirs, and immunoregulatory cells in human immunodeficiency virus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

A role for the aspartyl protease from the human immunodeficiency virus type 1 (HIV-1) in the orchestration of virus assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

Fibronectin is a non-viral substrate for the HIV proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

Potential role of the viral protease in human immunodeficiency virus type 1 associated pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

Receptor blockade as a mechanism of deactivation of human neutrophils by pepstatin and formyl-met-leu-phe

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

Evolution in the structure and function of aspartic proteases

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

Calcium-free calmodulin is a substrate of proteases from human immunodeficiency viruses 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

Cerebrospinal fluid concentration of fibronectin in patients with HIV-1 infection and central nervous system disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

Proteolytic cleavage of microtubule-associated proteins by retroviral proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

Are HIV-specific CTL responses salutary or pathogenic?

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2985129-1

7 January 2021

10.1016/S0923-2516(97)85129-1

Identifiers

DOI

1 reference

22 December 2017

release_kt5yogyf45auzpmufdtqn7mk64

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kt5yogyf45auzpmufdtqn7mk64

24 November 2022

mapped directly with Wikidata item

PubMed ID

8958590

1 reference

22 December 2017